Dementia Treatment Global Market Report 2025

Description

Dementia treatment involves a combination of medical, psychological, and supportive approaches aimed at managing symptoms and slowing the progression of the condition, which is characterized by memory loss, cognitive decline, and difficulty with reasoning. Early detection of dementia enables more effective intervention and facilitates the preparation of long-term care plans. Tailored treatment strategies, based on the specific type and stage of dementia, can enhance the quality of life for those affected.

The primary treatment options for dementia include antipsychotics, cholinesterase inhibitors, memantine, and others. Antipsychotic medications are prescribed to manage behavioral and psychological symptoms in dementia patients, such as aggression, agitation, and hallucinations. These medications are used to treat various forms of dementia, including Alzheimer's disease dementia, vascular dementia, Lewy body dementia, frontotemporal dementia, Parkinson's disease dementia, and others. Antipsychotics can be administered via oral tablets, transdermal patches, or injectables, and are used for managing mild, moderate, and severe stages of dementia. They are typically distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The dementia treatment market research report is one of a series of new reports from The Business Research Company that provides dementia treatment market statistics, including dementia treatment industry global market size, regional shares, competitors with a dementia treatment market share, detailed dementia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the dementia treatment industry. This dementia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dementia treatment market size has grown strongly in recent years. It will grow from $18.32 billion in 2024 to $20.14 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period can be attributed to factors such as the aging population, improved diagnosis rates, greater awareness of dementia, the expansion of healthcare infrastructure, and increased government funding for dementia research and treatment.

The dementia treatment market size is expected to see strong growth in the next few years. It will grow to $29.12 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth during the forecast period can be attributed to factors such as increased healthcare expenditure, a higher prevalence of chronic diseases, more clinical trials, growth in the pharmaceutical industry, and rising rates of Alzheimer's disease. Key trends in the forecast period include advancements in scientific research, the use of artificial intelligence and machine learning for diagnosis and treatment management, the development of new drugs and therapies, increased investment in biotechnology, and progress in personalized treatment approaches.

The rising prevalence of neurodegenerative disorders is expected to drive the growth of the dementia treatment market in the coming years. Neurodegenerative disorders, which involve the progressive degeneration and loss of nerve cells, lead to impairments in movement, cognition, or both. This increase in neurodegenerative disorders is largely attributed to the aging population, as longer life expectancy raises the risk of age-related conditions such as Alzheimer's and Parkinson's disease, with age being the primary contributing factor. A deeper understanding of neurodegenerative disorders enhances dementia treatment by enabling more accurate diagnoses and targeted therapies, allowing for a more personalized and effective approach to managing symptoms. For instance, according to a report published in April 2024 by the Alzheimer's Association, approximately 6.9 million Americans aged 65 and older were affected by Alzheimer's dementia, with projections suggesting this number will double to 13.8 million by 2060. As a result, the growing prevalence of neurodegenerative disorders will significantly drive the growth of the dementia treatment market.

Leading companies in the dementia treatment sector are concentrating on developing advanced technological solutions, such as virtual reality (VR) training programs, to replicate intricate and varied scenarios. VR training programs are immersive, computer-generated experiences that provide individuals with the opportunity to practice and refine their skills in a controlled, interactive, and realistic virtual setting. For example, in September 2024, Otsuka Pharmaceutical Co. Ltd., based in Japan, collaborated with Jolly Good Inc., a medical technology company from Japan, to introduce FACEDUO, a VR training program tailored for dementia care. This interactive VR tool, overseen by medical professionals, assists caregivers, including family members, in understanding the emotions and behaviors of individuals with dementia. By simulating real-life situations, the program enables caregivers to respond more effectively to the specific needs of dementia patients. Its primary goal is to enhance caregiving abilities and foster empathy for more impactful support.

In April 2024, Rippl, a US-based provider specializing in dementia care, acquired Kinto for an undisclosed sum. This acquisition aims to expedite the development of Rippl's dementia care platform by integrating artificial intelligence (AI)-driven solutions to enhance patient care. Kinto, a US-based AI healthcare company, focuses specifically on dementia care.

Major players in the dementia treatment market are Roche Holding AG, AbbVie Inc., Sanofi S.A., Eli Lilly and Company, Amgen Inc., Biogen Inc., Eisai Co. Ltd., Merz Pharmaceuticals GmbH, Acadia Pharmaceuticals Inc., Intra-Cellular Therapies Inc., Cerevance Inc., Retro Biosciences Inc., AviadoBio Ltd., MapHabit Inc., Neuvivo Inc., Harmonic Health Inc., Rippl Care Inc., Isaac Health Inc., EmTech Care Labs Inc., and LifeBio Inc.

North America was the largest region in the dementia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dementia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the dementia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dementia treatment market consists of revenues earned by entities by providing services such as medication management, cognitive therapy and stimulation, and behavioral and psychological support. The market value includes the value of related goods sold by the service provider or included within the service offering. The dementia treatment market also includes sales of memory-enhancing medications, nutritional supplements, cognitive stimulation tools, and medical alert systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dementia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dementia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dementia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dementia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment Type: Antipsychotics; Cholinesterase Inhibitors; Memantine; Other Treatment Types
2) By Indication: Alzheimer's Disease Dementia; Vascular Dementia; Lewy Body Dementia; Frontotemporal Dementia; Parkinson Disease Dementia; Other Indications
3) By Route of Administration: Oral; Transdermal Patch; Injectable
4) By Stage of Dementia: Mild Dementia; Moderate Dementia; Severe Dementia
5) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
Subsegments:
1) By Antipsychotics: Atypical Antipsychotics; Typical Antipsychotics
2) By Cholinesterase Inhibitors: Donepezil; Rivastigmine; Galantamine
3) By Memantine: Memantine Monotherapy; Memantine Combination Therapy
4) By Other Treatment Types: Cognitive Enhancers; NMDA Receptor Antagonists; Nutritional And Herbal Supplements; Hormonal Treatments; Stem Cell Therapy
Companies Mentioned: Roche Holding AG; AbbVie Inc.; Sanofi S.A.; Eli Lilly and Company; Amgen Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r35391

1. Executive Summary

2. Dementia Treatment Market Characteristics

3. Dementia Treatment Market Trends And Strategies

4. Dementia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Dementia Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Dementia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Dementia Treatment Market Growth Rate Analysis
5.4. Global Dementia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Dementia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Dementia Treatment Total Addressable Market (TAM)

6. Dementia Treatment Market Segmentation

6.1. Global Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antipsychotics
Cholinesterase Inhibitors
Memantine
Other Treatment Types
6.2. Global Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alzheimer's Disease Dementia
Vascular Dementia
Lewy Body Dementia
Frontotemporal Dementia
Parkinson Disease Dementia
Other Indications
6.3. Global Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Transdermal Patch
Injectable
6.4. Global Dementia Treatment Market, Segmentation By Stage of Dementia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mild Dementia
Moderate Dementia
Severe Dementia
6.5. Global Dementia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.6. Global Dementia Treatment Market, Sub-Segmentation Of Antipsychotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Atypical Antipsychotics
Typical Antipsychotics
6.7. Global Dementia Treatment Market, Sub-Segmentation Of Cholinesterase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Donepezil
Rivastigmine
Galantamine
6.8. Global Dementia Treatment Market, Sub-Segmentation Of Memantine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Memantine Monotherapy
Memantine Combination Therapy
6.9. Global Dementia Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cognitive Enhancers
NMDA Receptor Antagonists
Nutritional And Herbal Supplements
Hormonal Treatments
Stem Cell Therapy

7. Dementia Treatment Market Regional And Country Analysis

7.1. Global Dementia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Dementia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dementia Treatment Market

8.1. Asia-Pacific Dementia Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dementia Treatment Market

9.1. China Dementia Treatment Market Overview
9.2. China Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dementia Treatment Market

10.1. India Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dementia Treatment Market

11.1. Japan Dementia Treatment Market Overview
11.2. Japan Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dementia Treatment Market

12.1. Australia Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dementia Treatment Market

13.1. Indonesia Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dementia Treatment Market

14.1. South Korea Dementia Treatment Market Overview
14.2. South Korea Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dementia Treatment Market

15.1. Western Europe Dementia Treatment Market Overview
15.2. Western Europe Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dementia Treatment Market

16.1. UK Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dementia Treatment Market

17.1. Germany Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dementia Treatment Market

18.1. France Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dementia Treatment Market

19.1. Italy Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dementia Treatment Market

20.1. Spain Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dementia Treatment Market

21.1. Eastern Europe Dementia Treatment Market Overview
21.2. Eastern Europe Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dementia Treatment Market

22.1. Russia Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dementia Treatment Market

23.1. North America Dementia Treatment Market Overview
23.2. North America Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dementia Treatment Market

24.1. USA Dementia Treatment Market Overview
24.2. USA Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dementia Treatment Market

25.1. Canada Dementia Treatment Market Overview
25.2. Canada Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dementia Treatment Market

26.1. South America Dementia Treatment Market Overview
26.2. South America Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dementia Treatment Market

27.1. Brazil Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dementia Treatment Market

28.1. Middle East Dementia Treatment Market Overview
28.2. Middle East Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dementia Treatment Market

29.1. Africa Dementia Treatment Market Overview
29.2. Africa Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dementia Treatment Market Competitive Landscape And Company Profiles

30.1. Dementia Treatment Market Competitive Landscape
30.2. Dementia Treatment Market Company Profiles
- 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Dementia Treatment Market Other Major And Innovative Companies

31.1. Biogen Inc.
31.2. Eisai Co. Ltd.
31.3. Merz Pharmaceuticals GmbH
31.4. Acadia Pharmaceuticals Inc.
31.5. Intra-Cellular Therapies Inc.
31.6. Cerevance Inc.
31.7. Retro Biosciences Inc.
31.8. AviadoBio Ltd.
31.9. MapHabit Inc.
31.10. Neuvivo Inc.
31.11. Harmonic Health Inc.
31.12. Rippl Care Inc.
31.13. Isaac Health Inc.
31.14. EmTech Care Labs Inc.
31.15. LifeBio Inc.

32. Global Dementia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dementia Treatment Market

34. Recent Developments In The Dementia Treatment Market

35. Dementia Treatment Market High Potential Countries, Segments and Strategies

35.1 Dementia Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Dementia Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Dementia Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer